Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06907082

Completed

Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Based on Dual Blockade With Pertuzumab and the Trastuzumab Biosimilar CT-P6 (Herzuma®) in Early HER2-positive Breast Cancer in Routine Clinical Practice (Her-Database)

Breast Cancer
NCT05905939

Completed

HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

Breast Cancer
NCT05615753

Completed

Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors

Breast Cancer
NCT03785782

Completed

ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer

Breast Cancer
NCT02625441

Active, not recruiting

Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer (BOLD-1)

Breast Cancer
NCT06390241

Terminated

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer (ARTHE)

Breast Cancer
NCT01817452

Completed

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol (ADAPT)

Breast Cancer
NCT03329937

Completed

Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer

Neoplasms, Breast
NCT03092635

Terminated

AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

Breast Cancer
NCT00470704

Completed

Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

Breast Cancer
NCT00999804

Active, not recruiting

Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy (HELEX)

Breast Cancer
NCT05384119

Terminated

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Breast Cancer
NCT02437318

Completed

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. (SOLAR-1)

Breast Cancer
NCT05184257

Completed

Zoladex® 10.8 BC RWS

Breast Cancer
NCT01160211

Completed

A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Neoplasms, Breast
NCT03936933

Terminated

Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer

Breast Cancer
NCT05732428

Completed

A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China

Breast Cancer
NCT02370797

Active, not recruiting

Node Negative, Invasive Breast Cancer Single Fraction IOERT

Breast Cancer
NCT03980509

Completed

A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Breast Cancer
NCT04450264

Completed

Increasing African Immigrant Women's Participation in Breast Cancer Screening (AIBCS)

Breast Cancer
NCT03623945

Terminated

Autoantibodies in Breast Cancer Detection (ABCD)

Breast Cancer
NCT05821244

Completed

Exercise Timing in Breast Cancer Patients

Breast Cancer
NCT06706141

Completed

The Effect of Breast Cancer and Breast Self-Examination

Breast Carcinoma
NCT02890095

Active, not recruiting

Persistent Organic Pollutants and Breast Cancers (POPCASE) (POPCASE)

Breast Cancer
NCT05592483

Terminated

An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer (DB RESPOND)

Breast Cancer
NCT05571618

Active, not recruiting

The Rechallenge of ADCs in MBC Patients

Breast Cancer
NCT02046057

Completed

Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast Cancer (ENCASe)

Breast Cancer
NCT06022900

Completed

The Effect of Health Education on Breast Cancer

Breast Cancer
NCT03656731

Completed

Exercise in Older Women With Breast Cancer During Systemic Therapy

Breast Cancer
NCT05650086

Terminated

Novel Thermal Imaging Technique for Breast Screening

Breast Cancer
NCT05963412

Completed

Online Individual Intervention Program to Make Sense of People's Experiences After a Breast Cancer Diagnosis

Breast Cancer
NCT06578988

Active, not recruiting

Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting

Cancer, Breast
NCT00725374

Completed

A Study to Investigate the Effects of Tibolone (Livial®) on Breast Tissue in Postmenopausal Women With Breast Cancer (Study 32971)(P06469) (STEM)

Breast Cancer
NCT06549920

Active, not recruiting

Danish Breast Cancer Group Internal Mammary Node Study (DBCG IMN)

Breast Cancer
NCT03451162

Completed

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

Breast Cancer
NCT06531447

Active, not recruiting

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Breast Cancer
NCT02053636

Completed

A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

Breast Cancer
NCT05868746

Completed

An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer Survivors

Breast Cancer
NCT03650803

Completed

Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer

Breast Cancer
NCT05163223

Terminated

Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)

Breast Cancer
NCT00291304

Terminated

Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma

Breast Neoplasms
NCT04925817

Completed

3D Ultrasound Microvessel Imaging for Breast Masses

Breast Carcinoma
NCT04106609

Completed

Individualized Exercise Oncology Program for Newly Diagnosed Breast Cancer Patients

Breast Cancer
NCT01618357

Completed

Pre-Operative Radiation and Veliparib for Breast Cancer

Breast Cancer
NCT00796978

Completed

Trastuzumab in Treating Older Women With Early-Stage Breast Cancer

Breast Cancer
NCT06357689

Completed

Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population

Breast Cancer
NCT00003782

Completed

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Breast Cancer
NCT03841747

Withdrawn

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer (PELICAN)

Breast Cancer
NCT01822314

Completed

Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer (ETNA)

Breast Cancer
NCT03308201

Completed

Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations